Guest guest Posted March 5, 2011 Report Share Posted March 5, 2011 The research showed that the breast cancer patients given chemotherapy drug called eribulin can prolong life on average 2.5 months longer than patients who did not receive this treatment. HealthyLifestyle Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.